Autolus Therapeutics plc (NASDAQ:AUTL) Receives Average Rating of “Buy” from Analysts
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the […]
